Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.56 +0.00 (+0.41%)
As of: Sep 30, 2026 · 1:19 PM EDT

Citius Pharmaceuticals, Inc. (CTXR) Revenue (2025 - 2026)

Updated

Citius Pharmaceuticals (CTXR) posted Revenue of $1.49 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 10.4% from the prior quarter.

Analysis

Citius Pharmaceuticals, Inc. (CTXR) Revenue (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Citius Pharmaceuticals was $7.11 million.

Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.49 Mn
Mar 31, 2026 1.67 Mn
Dec 31, 2025 3.94 Mn
API Access

Citius Pharmaceuticals, Inc. Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CTXR&period=max&api_key=YOUR_API_KEY